Index of reports
> Cases with Dyspnoea (24)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Torsemide where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Torsemide side effects in 77 year old female
Reported by a physician from Germany on 2012-07-30
Patient: 77 year old female, weighing 61.0 kg (134.2 pounds)
Reactions: Dyspnoea, Cardiac Failure, Loss of Consciousness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupro
Indication: Parkinson's Disease
Start date: 2010-04-09
End date: 2010-05-05
Isosorbide Dinitrate
Indication: Hypertension
Start date: 2010-05-20
End date: 2010-06-09
Diovan
Indication: Hypertension
Start date: 2010-05-20
Aspirin
Indication: Cardiac Disorder
Neupro
Start date: 2010-05-28
Torsemide
Indication: Hypertension
Digitoxin TAB
Indication: Cardiac Disorder
Falithrom
Indication: Cardiac Failure
Start date: 2010-05-20
End date: 2010-06-09
Bisoprolol Fumarate
Indication: Arrhythmia
Neupro
Start date: 2010-05-06
End date: 2010-05-27
Other drugs received by patient: Pantoprazole; Ramipril; Felopuren; Simvastatin; Allopurinol; Nephrotrans; Valproate Sodium
Possible Torsemide side effects in 46 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02
Patient: 46 year old female, weighing 180.0 kg (396.0 pounds)
Reactions: Skin Chapped, Dyspnoea, Excoriation, Skin Exfoliation, Adverse Drug Reaction, Pain, Urticaria, Anaphylactic Shock, Faecal Incontinence, Skin Irritation, Diarrhoea, Rash Erythematous, Skin Lesion, Dermatitis Exfoliative, Rash Vesicular
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Savella
Administration route: Oral
Indication: Fibromyalgia
Start date: 2011-09-07
End date: 2011-09-12
Crestor
Dosage: 20mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-01
Ibuprofen
Dosage: 800mg three times per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-01
Lovaza
Dosage: 4g per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-07
Prilosec
Dosage: 20mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-01
Torsemide
Dosage: 40mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-07-13
Other drugs received by patient: Propranolol; Synthroid; Glimepiride; Adipex-P; Cinnamon; Cranberry; Fenofibrate; Vitamin D; Potassium; Warfarin Sodium; Vicodin; Metformin HCL; Oxybutynin; Amitriptyline HCL; Lisinopril; Amoxicillin; M.v.i.; Allopurinol; Wellbutrin
Possible Torsemide side effects in 56 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29
Patient: 56 year old male, weighing 77.6 kg (170.6 pounds)
Reactions: Dyspnoea, Syncope, Incorrect Dose Administered, Laceration, Dizziness, Fall, Traumatic Haematoma, Hypovolaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Warfarin Sodium
Dosage: unk, (blinded) (1 in 1 d), oral
Administration route: Oral
Indication: Thrombosis Prophylaxis
Start date: 2010-10-07
End date: 2011-06-09
Warfarin Sodium
Dosage: unk, (blinded) (1 in 1 d), oral
Administration route: Oral
Indication: Thrombosis Prophylaxis
Start date: 2011-06-24
Torsemide
Dosage: 40 mg (20 mg, 2 in 1 d), oral
Administration route: Oral
Indication: Cardiac Failure Congestive
Start date: 2011-04-01
End date: 2011-06-17
Other drugs received by patient: Avapro; Coreg; Digoxin; Lunesta; Dofetilide; Novolog MIX 70 / 30; Tikosyn; Irbesartan
Possible Torsemide side effects in male
Reported by a individual with unspecified qualification from United States on 2012-06-28
Patient: male
Reactions: Syncope, Dyspnoea, Incorrect Dose Administered, Dizziness, Laceration, Fall, Hypovolaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Torsemide
Administration route: Oral
Indication: Cardiac Failure Congestive
Start date: 2011-04-01
End date: 2011-06-17
Warfarin Sodium
Administration route: Oral
Indication: Thrombosis Prophylaxis
Start date: 2010-10-07
End date: 2011-06-09
Warfarin Sodium
Administration route: Oral
Other drugs received by patient: Digoxin; Tikosyn; Digoxin; Avapro; Coreg; Lunesta; Dofetilide; Novolog; Irbesartanum
Possible Torsemide side effects in 82 year old male
Reported by a pharmacist from Switzerland on 2012-05-23
Patient: 82 year old male, weighing 80.0 kg (176.0 pounds)
Reactions: Jaundice, Liver Injury, Thrombosis, Hyperbilirubinaemia, Pulmonary Embolism, Drug Interaction, Cholestasis, Hepatitis, Abdominal Pain Upper, Hyperventilation, Gamma-Glutamyltransferase Increased, Hepatotoxicity, Blood Alkaline Phosphatase Increased, Dyspnoea, Vomiting, Alanine Aminotransferase Increased, Condition Aggravated, General Physical Health Deterioration, Renal Failure Chronic, Diarrhoea, Aspartate Aminotransferase Increased, Gastroenteritis, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Rifampicin
Dosage: 900 mg (450 mg, 2 in 1 d), oral
Administration route: Oral
Indication: Infection
Start date: 2011-12-01
End date: 2012-01-03
Xarelto
Dosage: 10 mg (10 mg, 1 in 1 d), oral
Administration route: Oral
Start date: 2011-01-01
End date: 2012-01-03
Plavix
Dosage: 75 mg (75 mg, 1 in 1 d), oral
Administration route: Oral
End date: 2011-01-01
Pantoprazole
Dosage: 40 mg (40 mg, 1 in 1 d), oral
Administration route: Oral
End date: 2012-01-05
Atacand
Dosage: 0.5 dosage forms (0.5 dosage forms, 1 in 1 d), oral
Administration route: Oral
End date: 2012-01-05
Torsemide
Dosage: 5 mg (5 mg, 1 in 1 d), oral
Administration route: Oral
End date: 2011-01-01
Minocin
Dosage: 200 mg (50 mg, 4 in 1 d), oral
Administration route: Oral
Indication: Infection
Start date: 2011-12-01
End date: 2012-01-05
Aspirin
Dosage: 100 mg (100 mg, 1 in 1 d), oral
Administration route: Oral
End date: 2012-01-05
Other drugs received by patient: Halcion; Metamucil (Plantago Ovata); Magnesiocard (Magnesium Aspartate Hydrochloride); Novalgin (Metamizole Sodium); Seretide (Fluticasone Propionate, Salmeterol Xinafoate); Duodart (Tamsulosin Hydrochloride, Dutasteride); Nebivolol HCL; Arteoptic (Carteolol Hydrochloride 2 Percent); Neurontin
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-05-14
Patient: male, weighing 130.0 kg (286.0 pounds)
Reactions: Dyspnoea, Refractory Anaemia, Gout, Diabetic Foot, Angina Pectoris, Impaired Work Ability, Myelodysplastic Syndrome, Left Ventricular Hypertrophy, Albumin Urine Present, Hypertensive Crisis, Creatinine Urine Increased, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Blood Pressure Diastolic Decreased
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Diovan HCT
Dosage: 160/12.5 mg per day
Administration route: Oral
Indication: Hypertension
Diovan
Dosage: 160 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
End date: 2009-03-19
Valsartan
Dosage: 320 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Doxazosin Mesylate
Dosage: 8 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-27
Rasilez
Dosage: 300 mg daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-11-14
End date: 2012-02-15
Torsemide
Dosage: 20 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-14
Lercanidipine
Dosage: 40 mg/d
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Diovan
Dosage: 320 mg,daily
Administration route: Oral
Start date: 2009-03-19
End date: 2011-01-10
Other drugs received by patient: Aspirin; Pantoprazole; Other Antihypertensives; Simvastatin; Nebivolol HCL; Humalog; Simvastatin; Metformin HCL; Insulin Human; Adenuric; Diuretics
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-05-14
Patient: male, weighing 130.0 kg (286.0 pounds)
Reactions: Dyspnoea, Refractory Anaemia, Diabetic Foot, Gout, Angina Pectoris, Impaired Work Ability, Left Ventricular Hypertrophy, Myelodysplastic Syndrome, Albumin Urine Present, Hypertensive Crisis, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Creatinine Urine Increased, Blood Pressure Diastolic Decreased
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Torsemide
Dosage: 20 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-14
Diovan
Dosage: 160 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
End date: 2009-03-19
Lercanidipine
Dosage: 40 mg/d
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Diovan HCT
Dosage: 160/12.5 mg per day
Administration route: Oral
Indication: Hypertension
Diovan
Dosage: 320 mg,daily
Administration route: Oral
Start date: 2009-03-19
End date: 2011-01-10
Rasilez
Dosage: 300 mg daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-11-14
End date: 2012-02-15
Valsartan
Dosage: 320 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Doxazosin Mesylate
Dosage: 8 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-27
Other drugs received by patient: Diuretics; Insulin Human; Adenuric; Nebivolol HCL; Simvastatin; Aspirin; Humalog; Pantoprazole; Metformin HCL; Other Antihypertensives; Simvastatin
Possible Torsemide side effects in 82 year old male
Reported by a pharmacist from Switzerland on 2012-05-11
Patient: 82 year old male, weighing 80.0 kg (176.0 pounds)
Reactions: Thrombosis, Jaundice, Renal Function Test Abnormal, Dyspnoea, Vomiting, General Physical Health Deterioration, Pulmonary Embolism, Drug Interaction, Abdominal Pain Upper, Hyperventilation, Death, Diarrhoea, Drug-Induced Liver Injury, Gastroenteritis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Atacand HCT
Dosage: 0.5 df, unk
End date: 2012-01-05
Pantoprazole
Dosage: 40 mg, qd
End date: 2012-01-05
Plavix
Dosage: 75 mg, unk
Torsemide
Dosage: 5 mg, unk
Aspirin
Dosage: 100 mg, qd
End date: 2012-01-05
Other drugs received by patient possibly interacting with the suspect drug: Xarelto
Dosage: 10 mg, unk
End date: 2012-01-03
Rimactane
Dosage: 450 mg, once/single
Start date: 2012-01-03
Rimactane
Dosage: 450 mg, bid
Administration route: Oral
Indication: Infection
End date: 2011-12-27
Minocin
Dosage: 2 df, bid
Indication: Infection
End date: 2012-01-05
Other drugs received by patient: Dutasteride / Tamsulosin Hydrochloride; Metamucil-2; Magnesiocard; Nebivolol HCL; Halcion; Neurontin; Arteoptic; Novalgin / SCH /
Possible Torsemide side effects in
Reported by a physician from Germany on 2012-05-08
Patient: , weighing 94.0 kg (206.8 pounds)
Reactions: Dyspnoea, Aortic Stenosis, Blood Pressure Systolic Increased, Coronary Artery Disease
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carmen ACE
Dosage: 1 df/day
Administration route: Oral
Indication: Hypertension
Start date: 2008-11-24
Thienopyridine
Metoprolol Tartrate
Dosage: 190 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2011-03-17
Berlinsulin
Dosage: 26 iu/day
Indication: Diabetes Mellitus
Start date: 2007-01-15
Metformin HCL
Dosage: 2000 mg/day
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-08-27
Rasilez
Dosage: (dose decreased)
End date: 2012-02-01
Torsemide
Dosage: 20 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2011-04-11
Doxazosin Mesylate
Dosage: 8 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2011-03-17
Pentaerythritol Tetranitrate
Dosage: 160 mg,/say
Administration route: Oral
Indication: Angina Pectoris
Start date: 2011-03-17
End date: 2011-06-16
Rasilez
Dosage: 150 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2008-11-24
End date: 2012-02-01
Berlinsulin Basal
Dosage: 16 iu/day
Indication: Diabetes Mellitus
Start date: 2009-06-15
Other drugs received by patient: Beta Blocking Agents; Platelet Aggregation Inhibitors; Inhibitors OF Nsaid Group; Diuretics; ACE Inhibitors; Calcium Channel Blockers; ACE Inhibitors; Vasodilators Used IN Cardiac Diseases; HMG COA Reductase Inhibitors
Possible Torsemide side effects in
Reported by a physician from Germany on 2012-05-08
Patient: , weighing 94.0 kg (206.8 pounds)
Reactions: Dyspnoea, Aortic Stenosis, Blood Pressure Systolic Increased, Coronary Artery Disease
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Torsemide
Dosage: 20 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2011-04-11
Rasilez
Dosage: (dose decreased)
End date: 2012-02-01
Doxazosin Mesylate
Dosage: 8 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2011-03-17
Berlinsulin Basal
Dosage: 16 iu/day
Indication: Diabetes Mellitus
Start date: 2009-06-15
Metformin HCL
Dosage: 2000 mg/day
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-08-27
Thienopyridine
Rasilez
Dosage: 150 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2008-11-24
End date: 2012-02-01
Pentaerythritol Tetranitrate
Dosage: 160 mg,/say
Administration route: Oral
Indication: Angina Pectoris
Start date: 2011-03-17
End date: 2011-06-16
Metoprolol Tartrate
Dosage: 190 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2011-03-17
Carmen ACE
Dosage: 1 df/day
Administration route: Oral
Indication: Hypertension
Start date: 2008-11-24
Berlinsulin
Dosage: 26 iu/day
Indication: Diabetes Mellitus
Start date: 2007-01-15
Other drugs received by patient: ACE Inhibitors; Beta Blocking Agents; Platelet Aggregation Inhibitors; ACE Inhibitors; Diuretics; Calcium Channel Blockers; HMG COA Reductase Inhibitors; Vasodilators Used IN Cardiac Diseases; Inhibitors OF Nsaid Group
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-05-04
Patient: male, weighing 130.0 kg (286.0 pounds)
Reactions: Refractory Anaemia, Dyspnoea, Diabetic Foot, Gout, Angina Pectoris, Impaired Work Ability, Myelodysplastic Syndrome, Left Ventricular Hypertrophy, Hypertensive Crisis, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Creatinine Urine Increased, Blood Pressure Diastolic Decreased
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Diovan HCT
Dosage: 1 df, unk
Administration route: Oral
Indication: Hypertension
Diovan
Dosage: 160 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
End date: 2009-03-19
Rasilez
Dosage: 300 mg daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-11-14
End date: 2012-02-15
Valsartan
Dosage: 320 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Torsemide
Dosage: 20 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-14
Doxazosin Mesylate
Dosage: 8 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-27
Lercanidipine
Dosage: 40 mg/d
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Diovan
Dosage: 320 mg,daily
Administration route: Oral
Start date: 2009-03-19
End date: 2011-01-10
Other drugs received by patient: Humalog; Adenuric; Metformin HCL; Simvastatin; Insulin Human; Simvastatin; Pantoprazole; Diuretics; Aspirin; Nebivolol HCL; Other Antihypertensives
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-05-04
Patient: male, weighing 130.0 kg (286.0 pounds)
Reactions: Dyspnoea, Refractory Anaemia, Angina Pectoris, Gout, Diabetic Foot, Impaired Work Ability, Left Ventricular Hypertrophy, Myelodysplastic Syndrome, Hypertensive Crisis, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Creatinine Urine Increased, Blood Pressure Diastolic Decreased
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Rasilez
Dosage: 300 mg daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-11-14
End date: 2012-02-15
Diovan
Dosage: 160 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
End date: 2009-03-19
Torsemide
Dosage: 20 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-14
Diovan HCT
Dosage: 1 df, unk
Administration route: Oral
Indication: Hypertension
Valsartan
Dosage: 320 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Doxazosin Mesylate
Dosage: 8 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-27
Diovan
Dosage: 320 mg,daily
Administration route: Oral
Start date: 2009-03-19
End date: 2011-01-10
Carmen
Dosage: 40 mg/d
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Other drugs received by patient: Diuretics; Other Antihypertensives; Nebivolol HCL; Aspirin; Simvastatin; Pantoprazole; Metformin HCL; Insulin Human; Adenuric; Humalog; Simvastatin
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-05-03
Patient: male, weighing 95.0 kg (209.0 pounds)
Reactions: Blood Pressure Increased, Dyspnoea, Angina Pectoris, Congestive Cardiomyopathy, Bundle Branch Block Left, Left Ventricular Dysfunction, Ejection Fraction Decreased, Atrioventricular Block, Obstructive Airways Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rasilez
Dosage: 300 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2008-11-27
Torsemide
Dosage: 20 mg, qd
Administration route: Oral
Start date: 2011-01-01
Metformin HCL
Dosage: 2000 mg, qd
Administration route: Oral
Start date: 2008-01-01
Other drugs received by patient: Bisoprolol Fumarate; Omeprazole; Spironolactone; Oral Antidiabetics
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-05-03
Patient: male, weighing 95.0 kg (209.0 pounds)
Reactions: Blood Pressure Increased, Dyspnoea, Angina Pectoris, Bundle Branch Block Left, Congestive Cardiomyopathy, Left Ventricular Dysfunction, Ejection Fraction Decreased, Atrioventricular Block, Obstructive Airways Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rasilez
Dosage: 300 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2008-11-27
Torsemide
Dosage: 20 mg, qd
Administration route: Oral
Start date: 2011-01-01
Metformin HCL
Dosage: 2000 mg, qd
Administration route: Oral
Start date: 2008-01-01
Other drugs received by patient: Omeprazole; Spironolactone; Bisoprolol Fumarate; Oral Antidiabetics
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-04-10
Patient: male, weighing 95.0 kg (209.0 pounds)
Reactions: Blood Pressure Increased, Dyspnoea, Left Ventricular Dysfunction, Angina Pectoris, Ejection Fraction Decreased, Congestive Cardiomyopathy, Bundle Branch Block Left, Obstructive Airways Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rasilez
Dosage: 300 mg, qd
Administration route: Oral
Start date: 2008-11-27
Torsemide
Dosage: 20 meq/kg, qd
Administration route: Oral
Metformin HCL
Dosage: 2000 mg, qd
Administration route: Oral
Start date: 2008-01-01
Other drugs received by patient: Spironolactone; Oral Antidiabetics; Omeprazole; Bisoprolol Fumarate
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-04-10
Patient: male, weighing 95.0 kg (209.0 pounds)
Reactions: Blood Pressure Increased, Dyspnoea, Left Ventricular Dysfunction, Angina Pectoris, Ejection Fraction Decreased, Bundle Branch Block Left, Congestive Cardiomyopathy, Obstructive Airways Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Torsemide
Dosage: 20 meq/kg, qd
Administration route: Oral
Rasilez
Dosage: 300 mg, qd
Administration route: Oral
Start date: 2008-11-27
Metformin HCL
Dosage: 2000 mg, qd
Administration route: Oral
Start date: 2008-01-01
Other drugs received by patient: Omeprazole; Bisoprolol Fumarate; Oral Antidiabetics; Spironolactone
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-04-10
Patient: male, weighing 95.0 kg (209.0 pounds)
Reactions: Blood Pressure Increased, Dyspnoea, Left Ventricular Dysfunction, Angina Pectoris, Ejection Fraction Decreased, Congestive Cardiomyopathy, Bundle Branch Block Left, Obstructive Airways Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Torsemide
Dosage: 20 meq/kg, qd
Administration route: Oral
Metformin HCL
Dosage: 2000 mg, qd
Administration route: Oral
Start date: 2008-01-01
Rasilez
Dosage: 300 mg, qd
Administration route: Oral
Start date: 2008-11-27
Other drugs received by patient: Omeprazole; Bisoprolol Fumarate; Spironolactone; Oral Antidiabetics
Possible Torsemide side effects in 85 year old male
Reported by a health professional (non-physician/pharmacist) from Sweden on 2012-04-03
Patient: 85 year old male
Reactions: Fatigue, Dyspnoea, Dehydration, Blood Creatinine Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Torsemide
Dosage: 40;20 mg (40 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Cardiac Disorder
Start date: 2012-01-01
Torsemide
Dosage: 40;20 mg (40 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Cardiac Disorder
Start date: 2012-01-02
End date: 2012-01-02
Warfarin Sodium
End date: 2012-01-02
Spironolactone
Dosage: 12 mg (12 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Cardiac Disorder
End date: 2012-01-02
Other drugs received by patient: Enalapril Maleate; Simvastatin; Selokenzoc (Metoprolol Succinate); Imdur; Panocod (Paracetamol, Codeine Phosphate Hemihydrate); Acetaminophen; Mollepect (Bromphexinhydrochloride, Ephedrinehydrochloride)
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-03-14
Patient: male, weighing 95.0 kg (209.0 pounds)
Reactions: Blood Pressure Increased, Left Ventricular Dysfunction, Dyspnoea, Angina Pectoris, Atrioventricular Block, Bundle Branch Block Left, Congestive Cardiomyopathy, Obstructive Airways Disorder
Drug(s) suspected as cause:
Torsemide
Dosage: 20 meq/kg, qd
Administration route: Oral
Start date: 2011-10-31
Bisoprolol Fumarate
Dosage: 2.5 mg, qd
Administration route: Oral
Start date: 2011-10-31
Spironolactone
Dosage: 25 mg, qd
Administration route: Oral
Start date: 2011-10-31
Omeprazole
Dosage: 20 mg, qd
Administration route: Oral
Start date: 2011-10-31
Metformin
Dosage: 2000 mg, qd
Administration route: Oral
Start date: 2011-10-31
Rasilez
Dosage: 300 mg, qd
Administration route: Oral
Other drugs received by patient: Oral Antidiabetics
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-03-14
Patient: male, weighing 95.0 kg (209.0 pounds)
Reactions: Blood Pressure Increased, Left Ventricular Dysfunction, Dyspnoea, Angina Pectoris, Congestive Cardiomyopathy, Bundle Branch Block Left, Atrioventricular Block, Obstructive Airways Disorder
Drug(s) suspected as cause:
Torsemide
Dosage: 20 meq/kg, qd
Administration route: Oral
Start date: 2011-10-31
Rasilez
Dosage: 300 mg, qd
Administration route: Oral
Bisoprolol Fumarate
Dosage: 2.5 mg, qd
Administration route: Oral
Start date: 2011-10-31
Omeprazole
Dosage: 20 mg, qd
Administration route: Oral
Start date: 2011-10-31
Metformin HCL
Dosage: 2000 mg, qd
Administration route: Oral
Start date: 2011-10-31
Spironolactone
Dosage: 25 mg, qd
Administration route: Oral
Start date: 2011-10-31
Other drugs received by patient: Oral Antidiabetics
Possible Torsemide side effects in 80 year old female
Reported by a consumer/non-health professional from Germany on 2012-02-10
Patient: 80 year old female
Reactions: Abdominal Pain, Vomiting, Dyspnoea, Tachyarrhythmia, Nausea, Restlessness, Diverticulitis, Alanine Aminotransferase Increased, General Physical Health Deterioration, Cerebrovascular Accident, Alveolitis, Gamma-Glutamyltransferase Increased, Aspartate Aminotransferase Increased, Pulmonary Congestion, Pleural Effusion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Falithrom
Dosage: 3 mg, 1x/day
Administration route: Oral
Indication: Tachyarrhythmia
Start date: 2008-11-01
End date: 2009-05-04
Torsemide
Dosage: 200 mg, 1x/day
Administration route: Oral
Indication: Hypertension
Start date: 2008-11-01
Amlodipine
Dosage: 5 mg, 1x/day
Administration route: Oral
Indication: Hypertension
Start date: 2008-11-01
End date: 2009-05-15
Omeprazole
Dosage: 20 mg, 1x/day
Administration route: Oral
Indication: Prophylaxis Against Gastrointestinal Ulcer
Start date: 2008-11-01
End date: 2009-05-03
Altace
Dosage: 1.25 mg, 1x/day
Administration route: Oral
Start date: 2009-05-13
Methotrexate
Dosage: 10 ml, 1x/day
Indication: Rheumatoid Arthritis
Start date: 2008-11-01
End date: 2009-05-04
Simvastatin
Dosage: 40 mg, 1x/day
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2008-11-01
End date: 2009-05-05
Altace
Dosage: 2.5 mg, 1x/day
Administration route: Oral
Indication: Hypertension
Start date: 2000-01-01
End date: 2009-05-12
Cordanum
Dosage: 50 mg, 1x/day
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2009-05-04
Seroquel
Dosage: 25 mg, 1x/day
Administration route: Oral
Indication: Restlessness
Start date: 2008-11-01
Other drugs received by patient: Actonel; Digitoxin; Dreisafer; Folic Acid; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Xipamide
Possible Torsemide side effects in female
Reported by a consumer/non-health professional from United States on 2012-02-06
Patient: female, weighing 129.3 kg (284.4 pounds)
Reactions: Dyspnoea
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Torsemide
Possible Torsemide side effects in 80 year old female
Reported by a consumer/non-health professional from Germany on 2012-01-30
Patient: 80 year old female
Reactions: Abdominal Pain, Vomiting, Dyspnoea, Restlessness, Nausea, Tachyarrhythmia, Alanine Aminotransferase Increased, Diverticulitis, General Physical Health Deterioration, Cerebrovascular Accident, Alveolitis, Gamma-Glutamyltransferase Increased, Aspartate Aminotransferase Increased, Pulmonary Congestion, Pleural Effusion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Amlodipine
Dosage: 5 mg, 1x/day
Administration route: Oral
Indication: Hypertension
Start date: 2008-11-01
End date: 2009-05-15
Simvastatin
Dosage: 40 mg, 1x/day
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2008-11-01
End date: 2009-05-05
Altace
Dosage: 1.25 mg, 1x/day
Administration route: Oral
Start date: 2009-05-13
Altace
Dosage: 2.5 mg, 1x/day
Administration route: Oral
Indication: Hypertension
Start date: 2000-01-01
End date: 2009-05-12
Falithrom
Dosage: 3 mg, 1x/day
Administration route: Oral
Indication: Tachyarrhythmia
Start date: 2008-11-01
End date: 2009-05-04
Omeprazole
Dosage: 20 mg, 1x/day
Administration route: Oral
Indication: Prophylaxis Against Gastrointestinal Ulcer
Start date: 2008-11-01
End date: 2009-05-03
Cordanum
Dosage: 50 mg, 1x/day
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2009-05-04
Torsemide
Dosage: 200 mg, 1x/day
Administration route: Oral
Indication: Hypertension
Start date: 2008-11-01
Seroquel
Dosage: 25 mg, 1x/day
Administration route: Oral
Indication: Restlessness
Start date: 2008-11-01
Methotrexate
Dosage: 10 ml, 1x/day
Indication: Rheumatoid Arthritis
Start date: 2008-11-01
End date: 2009-05-04
Other drugs received by patient: Actonel; Dreisafer; Folic Acid; Digitoxin; Prednisolone; Prednisolone; Prednisolone; Xipamide; Prednisolone; Prednisolone
Possible Torsemide side effects in 61 year old male
Reported by a health professional (non-physician/pharmacist) from India on 2011-12-15
Patient: 61 year old male
Reactions: Respiratory Rate Increased, Confusional State, Dyspnoea, Pallor, Haemodialysis, Sepsis, NO Therapeutic Response, Hiccups, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Atenolol
Dosage: 75 mg
Amlodipine
Dosage: 7.5 mg
Teicoplanin
Indication: Sepsis
Arteether
Dosage: 150 mg once, daily
Amiloride Hydrochloride
Dosage: 40 mg
Ceftriaxone
Indication: Sepsis
Meropenem
Indication: Sepsis
Metolazone
Dosage: 5 mg once daily
Tigecycline
Dosage: 50 mg two times daily
Indication: Sepsis
Torsemide
Dosage: 20 mg two times daily
Cefotaxime
Dosage: 1 g two times daily
Indication: Sepsis
Doripenem Monohydrate
Dosage: 250 mg two times daily
Indication: Sepsis
Furosemide
Dosage: 40 mg two times daily
Tazobactam
Indication: Sepsis
Aspirin
Dosage: 50 mg once daily
Caspofungin Acetate
Dosage: 50 mg once daily
Indication: Sepsis
|